INFORMATION REQUIRED FROM PHARMACEUTICAL FIRMS FOR REGISRATION

Similar documents
SITE MASTER FILE For MHRA

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Annex 14 WHO guidelines for drafting a site master file 136

SRI LANKA STANDARDS INSTITUTION

GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE

Supersedes Division Name Revision No. 0 Export Division Page No. 1 of 9

DRUGS CONTROL ORGANISATION

The World Bank. Aide Memoire for use during GMP inspections

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.

Annex 4. Guidance on good manufacturing practices: inspection report. Background

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION

EudraLex. Part I1 Chapter 6: Quality Control

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union


Implementation & Documentation Requirements for ISO 22716:2007 Certification

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould

Self-Evaluation/Audit Checklist for Food Supplement Manufacturers

Prequalification of Medicines Programme

MINISTRY OF HEALTH ORDINANCE

Questionnaire Layout:

Brief Introduction of Aburaihan Company Organization Policy Organization Chart Qualified Human Resource Production Department Engineering Department

Local Pharmaceutical Manufacturer Licensing Procedure

Annex 13 WHO guidelines for preparing a laboratory information file

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

Pharmaceutical Good Manufacturing Practice. Contents are subject to change. For the latest updates visit

UGANDA NATIONAL BUREAU OF STANDARDS CERTIFICATION SCHEME

Good practices in quality control in pharmaceutical industry - Overview of regulatory guidelines

Overview of Regulatory Requirements for API and Formulations

Table of Contents Section 1: Section 2: Section 3: Section 4: Section 5: Section 6: Section 7:

GMP On Site Series. GMP Essentials

GMP GUIDELINES. GMP Guides from Industry Organisations. FDA cgmp WHO GMP. cgmp Guide Drugs 21 CFR 210 GAMP. ISPE Technical Guides

APPLICATION FOR VENDOR REGISTRATION Read the instructions and conditions at the end of this application format before preparing to fill-in the form.

Contents. Contents (13) 1 Production (23)

GOOD MANUFACTURING PRACTICES - AUDIT REPORT FORM AKA GMP Standards Program

GMP & Quality Assurance. Mayur Sushir Dept of Microbiology MJC

PIC/S Assessment & Joint Reassessment Programme REVISED PIC/S AUDIT CHECKLIST

Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets

Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS

Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer

Prequalification of Medicines Programme

MEDICINES CONTROL COUNCIL

18.H Questionnaire for preparing GMP-inspections

GOVERNMENT NOTICE NO. published on THE TANZANIA FOOD, DRUGS AND COSMETICS ACT (CAP 219) REGULATIONS. (Made under section 122(1)(o))

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products

MINISTRY OF COMMERCE, GOVERNMENT OF PAKISTAN

Guidance Document (Medical Devices and Diagnostic Division)

Section 3 Company Organisation and Certification Procedures

GMP Inspection Process. Types of GMP Inspection. Module 18 Slide 1 of 14 WHO - EDM

Document 2007 Rev 0 December 2005 Page 1 of 8

FORM VI. APPLICATION FOR GRANT OF REGISTRATION (see rule 16B) PIN: STD Code(s) to be given with Telephone and Fax numbers

Code of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products

Vendor Qualification Survey

ICH Q10/WHO TRS A Regulatory Perspective

SQF 2000 Code. 6th Edition AUGUST A HACCP-Based Supplier Assurance Code for the Food Manufacturing and Distributing Industries

PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME. PI July 2018

GUIDELINE FOR REGISTRATION OF MEDICINES

SUBCONTRACTOR PREQUALIFICATION REV G. If insufficient space, attach details of request and reference them in the space provided.

Registration and renewal of the credential certificate for registration

Quality Assessment & GMP Similarities & Differences

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:

TUV SUD BABT PRODUCTION QUALITY CERTIFICATION SCHEME

STANDARD OPERATING PROCEDURE TEAM INSPECTIONS

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines

GUIDANCE ON THE GMP CLEARANCE OF OVERSEAS MEDICINE MANUFACTURERS

Good manufacturing practices

IECEE OPERATIONAL DOCUMENT

IECEE OPERATIONAL DOCUMENT

Guidance Document. Meeting Requirements as a Registered Food Importer. A guidance document issued by the Ministry for Primary Industries

c) Have personnel been appointed to supervise the production operations across all shifts in order to ensure the product quality?

SUPPLIER QUALITY ASSESSMENT

QUALITY MANUAL DISTRIBUTION. Your Logo Here. Page 1 1 of 57. Rev.: A

Guidelines for application for Registration of Medicinal Products 2006(DRA)

Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer

PRE-QUALIFICATION FOR PROVISION OF TEAM BUILDING CONSULTANCY SERVICES TENDER NO. KPPF /HRA-B/1-A/22/17-18

Technical updates medicines inspections: Finished Pharmaceutical Products (FPP)

MDS-G25. Guidance on Requirements for Storage, Handling and Transportation of Medical Devices

Checklist for the Auditor

GMP The Other Side of Chemistry, Manufacturing & Controls (CMC)

QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION

Guidelines for the international procurement of vaccines and sera

Registration Application form for Vaccines (To be submitted in duplicate electronic copies)

UNICEF Quality Assurance in the procurement of medicines

PERMANENT DOCUMENT CIG 023. Factory Inspection Report

Equipment cleaning and use record

PRE-QUALIFICATION OF SUPPLIERS PROVISION OF FUMIGATION, SANITATION AND SANITAL DISPOSAL SERVICES TENDER NO.KPLC1/5BC/9A/PT-ST/113/2010

The Hashemite Kingdom of Jordan Jordan Institution for Standards & Metrology. Jordanian Quality Mark

EU and FDA GMP Regulations: Overview and Comparison

Comparison of Guidelines of Indian GMP with WHO GMP

Materials Management Traceability, CEPs and managing non-conforming sites

SAHARA Petrochemicals Company. Part I

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017

institutions and Public Sector Undertakings for similar works.

HACCP audit checklist

Webinar Expert Module 3: GMP Inspections Dupont

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION

Version Replaces Page Effective Supplier Qualification Questionnaire. Company Name:

PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT

Surveillance and CoP clearance

Transcription:

INFORMATION REQUIRED FROM PHARMACEUTICAL FIRMS FOR REGISRATION Part A: Details of the market Authorization holder (local agent)- 1. Name of Company: 2. Address and contact details of the company : 3. a) Registered office- Address: Telephone: Fax:.. Facsimile: Email: b) Operations office- Address: Telephone: Fax:.. Facsimile: Email: c) Ware house- Address: Telephone: Fax:.. Facsimile: Email: 4. Are you licensed market authorization holder in Sri Lanka, if so attached the copy of the license. 5. As per regulation ; Submit the declaration by the product license holder on contract manufacture 6. Copy of business registration: 7. Staff: Names of the Board of Directors: Responsible officers: a )Technical (Regulatory Affairs officer): b) Administration: (Full time, Part-time staff with qualifications and responsibilities) 8. Letter of appointment issued by head of the manufacturing site- 1

9. Details of the pharmacist who responsible for importing: Name: SLMC registration No: Telephone:. Email: 10. Give details of premises, equipment and facilities for the handling,storage and distribution of drugs which may import under his license are necessary to avoid deterioration of such drugs 11. Proposed post marketing surveillance plans: 12. Plan for recall procedure: 2

Part B-Business information on manufacturing company 1. Name of Company: 2. Address : Head Office:... Manufacturing Plant:... Indicate whether there are any other manufacturing plants: (Information on each manufacturing sites should be submitted separately, and will be evaluate and registered separately) 3. Nearest Airport: 4. Telephone: 5. Fax:. 6. Telex:. 7. Email: 8. Web site:... 8. Contact person: Telephone: Email: 9. Year of Establishment:. 10. Nature of the Company: Individual / Partnership/ Corporation 11. Names and Addresses of international pharmaceutical companies with whom there is collaboration or joint ventures, ( if any ): 12. Indicate whether any product completely or partly manufactured by other manufacturer for you. 13. Drug Manufacturing License Number issued by the Central Drug Authority and a copy of that certificate : To be valid for the date of submitted 14. Capital., Value of Authorized capital / Paid up capital/reserves 15. Total sales turnover in the previous three years -each year separately. Split between export and domestic sale. Year Domestic Export (Proof documents for export & domestic sales) 3

(Also three drug registration certificate (translation copies to be certified by the Embassy of the issuing country) in your own country as a proof of domestic sales) 16. Countries to which your drugs are presently exported and the names of the drugs exported to each country. (At least three Copies of drug registration certificate from three deferent countries for three deferent years). 17. Names of pharmaceuticals and/ or raw materials actually manufactured and which are available for export. (Attached list) 18. Indicate whether the products are not marketed by you in your own country. (If yes give reasons) 19. Show pharmaceuticals and /or raw materials manufactured by other companies and marketed by you. Please give names of these companies, against items. 20. Certificates Good Manufacturing Practices and Certificates of Pharmaceutical Products according to W.H.O Certification Scheme. ( Approved of central drug authority) 21. Site Master File Following details to be submitted with site master file 21.1.1General Information 1. Brief Information on site (name, address, other site) Annexure 2. Pharmaceutical manufacturing activities as licensed by the Competent Authorities 3. Any other manufacturing activities carried out on the site 4. Name and extract address of the site, 24 hour telephone number,fax, email, web site 5. Direction from the airport to manufacturing plant: 6. Does Government carry out inspections and controls with production of drugs in your country? 4

21.1.2Personnel 7. Organization chart Annexure 8. Qualification, experience and responsibilities of key personnel Name,designation and signature 9. Outline of arrangement for training programs 10. Health requirement for personnel engaged in production 11. Personal Hygiene requirement including clothing 21.1.3Premises 12. *Site lay out of the manufacturing plant (authorized qualified engineering drawing with describing all areas) 13. *Brief description of ventilation system (schematic drawings of the system) 14. *Brief description of water system(schematic drawings of the system) 15. *Brief description on maintenance system 16. *Special area for handling of highly toxic,hazardous and sanitizing materials 17. Cleaning procedures for manufacturing areas, equipment and machines *Above details to be authorized by designated qualified responsible person Annexure 5

21.2. Production Annexure Responsible person s name, designation, Qualification and experience 1. Type of actual product manufactured (Attached product list with product capacity) 2. Information about specially toxic or hazardous substances handled 3. Short description manufacturing activities (Are product manufactured routinely or Occasionally/Actually manufactured/ contract manufacturing 1 /loan license 2 ) 4. Whether Bio equivalence test are carried out if manufactured antibiotics, antiepileptic drugs and slow release or modified release preparations 5. Details regarding manufacturing Vaccine (Whether supplier is prequalified by WHO? If yes WHO prequalification certificate and product list to be attached) 6. Details regarding manufacturing Bio Technological Products? (Whether they followed WHO guideline? product list to be attaché separately) 7. Indicate whether any product completely or partly manufactured by other manufacturer for you? (Product list with name and address of manufacturers) 8. Number of employees engaged production, storage and distribution (Pharmacist & Others) 9. Brief description of product operation (Flow sheets, charts,specifying important parameters) 10. Brief description of equipment and machineries used in production? (Maintenance, Calibration& Validation) 11. Arrangement for the handling of starting materials,packaging materials, bulk and finish products, including sampling, quarantine, release and storage 12. Arrangement for reprocessing or rework 13. Arrangement of the handling of rejected materials and product 14. Brief description of general policy for process validation Above details to be authorized by designated qualified responsible person in production. 6

21.3. Quality Control &Assurance Cosmetics Devises and Drug Regulatory Authority, Sri Lanka Annexure Responsible person s name, designation, Qualification and experience 1. Number of specialized personnel in Quality Control &Assurance (Pharmacist, Chemist, Others)) 2. Name and address of quality control laboratories used in addition to your own laboratory. 3. Description of quality control/assurance system and activities of the department (Analytical testing, packaging component testing, biological & Microbiological testing) 4. Procedure of the release of finish product 5. Are raw materials completely tested prior to use? 6. Which standard are used in quality control?(bp/usp/ip etc) Are Additional test carried out? 7. Have Bio availability studies carried out on any of formulations? (List of product to be attached) 8. Are dissolution test carried out routinely 9. Are there performed stability test for any of the product 10. Brief description of Laboratory equipment?(maintenance, Calibration& Validation) 11. Procedure for handling quality failures Above details to be authorized by designated qualified responsible person in Quality Control & Assurance. 7

21.4. Documentation, Distribution, Complain, Product Recall & Self inspection Responsible person s name, designation, Qualification and experience for each and every task to be given 1. Arrangement for the preparation revision and distribution of necessary documentation for manufacturer, including storage of master documents 2. Arrangement and recording system for distribution 3. Arrangement for the handling of complaint, product recall and Pharmacovigilence 4. Short Description of the self-inspection system Annexure Explanatory notes: 1. A license which a Licensing Authority may issue to an applicant who does not have his own arrangements for manufacture but intends to avail him-self of the manufacturing facilities owned by a licensee. 2. This system prevails in many countries including developed countries. Contract manufacturer is a manufacturer who performs some aspect of manufacturing on behalf of the original manufacturer. This definition is included in the ICH and WHO Guidelines for GMP. 8

CERTIFICATION I, the undersigned (full name of the person responsible).. Hereby declare that all the information given above is true, and I take the full responsibility for all consequences, which might arise from false or erroneous information. If required, I will cooperate with any official of the Ministry of Health and manufacturing facilities and records. We hereby certify that the information given is true and that the company concerned fulfils the requirements of the local regulation concerning the manufacturing of pharmaceuticals... Head of the Company Name /Designation /Signature 9

Annexure 1 Certification by the Ministry of Health or the official authority in charge of the control and inspection of pharmaceutical Manufacturing facilities. (To be filled by authorized officer of above mentioned authority) 1. Name of Company:. 2. Address : Head Office:... Manufacturing Plant:... 3. Details on Manufacturing License: a. Manufacturing license No: b. Issuing date: c. Products which are approved for manufacture by the license: 4. Details of GMP Certificate: a) Certificate No b) Issuing Date c) Expiry date 5. Form of Company : Individual / Partnership/ Corporation 6. Attached Factory Layout : Satisfactory: Unsatisfactory: 7. Details on reporting: a. Quality failuresb. Adverse drug reactions - c. GMP violations- We hereby certify that the information given is true and that the company concerned fulfils the requirements of the local regulation concerning the manufacturing of pharmaceuticals. Name of the Authorized Officer: Contact Details: Signature/Date 10

Annexure- 2 Certification by the Chamber of Commerce or Similar Organization. (To be filled by authorized officer of above mentioned organization) 1. Name of Company:. 2. Address : Head Office:... Manufacturing Plant:... 3. Membership details on manufacturing plant on your organization. Membership No- Issued date- 4. Details on total sales turnover in the previous three years of the manufacturing plant. Year Domestic Export We hereby certify that the information given is true and that the company concerned fulfills the requirements of the local regulation concerning the manufacturing of pharmaceuticals. Name of the Authorized Officer: Contact Details: Signature/Date: 11